Shattuck Labs Inc

STTK
10,78
-0,32 (-2,88%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 22:00:10
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
02/5/202413:05GLOBEShattuck Labs Reports First Quarter 2024 Financial Results..
09/4/202422:05GLOBEShattuck Labs Announces Oral Presentation of Preclinical..
01/4/202413:00GLOBEShattuck Labs Announces Participation in Upcoming 23rd..
08/3/202423:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202423:29EDGAR2Form 3 - Initial statement of beneficial ownership of..
06/3/202422:42EDGAR2Form 144 - Report of proposed sale of securities
04/3/202413:14EDGAR2Form 8-K - Current report
04/3/202413:00GLOBEShattuck Labs Announces Appointment of Clay Siegall, Ph.D.,..
29/2/202422:41EDGAR2Form S-8 - Securities to be offered to employees in employee..
29/2/202422:23EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
29/2/202422:07EDGAR2Form 8-K - Current report
29/2/202422:05GLOBEShattuck Labs Reports Fourth Quarter and Full-Year 2023..
26/2/202413:00GLOBEShattuck Labs Announces Participation in Upcoming March..
14/2/202411:06PRNUSOno Enters into a Drug Discovery Collaboration and Option..
13/2/202412:07EDGAR2Form 8-K - Current report
13/2/202412:00GLOBEShattuck Labs Enters into Strategic Collaboration and..
02/2/202422:32EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
01/2/202406:15EDGAR2Form EFFECT - Notice of Effectiveness
31/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/1/202422:31EDGAR2Form S-3 - Registration statement under Securities Act of..
16/1/202422:42EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/1/202422:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/1/202422:05EDGAR2Form 144 - Report of proposed sale of securities
08/1/202413:00GLOBEShattuck Labs Provides Corporate Update and Highlights..
04/1/202422:05GLOBEShattuck Labs Announces Presentation at Upcoming 42nd Annual..
22/12/202322:30EDGAR2Form 8-K - Current report
22/12/202322:00EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
21/12/202314:00GLOBEShattuck Labs Announces $50 Million Public Offering of..
21/12/202313:31EDGAR2Form 8-K - Current report
13/12/202315:00APSSmall Cap Steals The Show With Wild Premarket Action
13/12/202312:10EDGAR2Form 8-K - Current report
13/12/202312:00GLOBEShattuck Labs Announces Positive Initial Topline Data from..
05/12/202322:15GLOBEShattuck Labs to Host Investor Call and Webcast to Share..
14/11/202315:00GLOBEShattuck Labs Announces Participation in Upcoming 6th Annual..
09/11/202313:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/11/202313:01EDGAR2Form 8-K - Current report
09/11/202312:00GLOBEShattuck Labs Reports Third Quarter 2023 Financial Results..
06/11/202315:28GLOBEShattuck Labs to Report Third-Quarter 2023 Financial Results..
02/11/202314:01GLOBEShattuck Labs to Present Topline Data from Phase 1 A/B..
10/8/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/8/202322:03EDGAR2Form 8-K - Current report
10/8/202322:00GLOBEShattuck Labs Reports Second Quarter 2023 Financial Results..
25/5/202323:15GLOBEShattuck Labs to Present Complete Dose-Escalation Data from..
09/5/202322:00GLOBEShattuck Labs Reports First Quarter 2023 Financial Results..
Apertura: 11,34 Min: 10,745 Max: 11,62
Chiusura: 11,10

La tua Cronologia

Delayed Upgrade Clock

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network